Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-07-06
DOI
10.1002/jcsm.12307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017
- (2017) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma
- (2016) Katie E. Rollins et al. CLINICAL NUTRITION
- Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
- (2016) Bjørg Sjøblom et al. CLINICAL NUTRITION
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- STAT3 in the systemic inflammation of cancer cachexia
- (2016) Teresa A. Zimmers et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
- (2016) Rafael Barreto et al. Oncotarget
- Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
- (2016) Rafael Barreto et al. Frontiers in Physiology
- Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review
- (2015) I. Ozola Zalite et al. PANCREATOLOGY
- Cancer cachexia, mechanism and treatment
- (2015) Tomoyoshi Aoyagi et al. World Journal of Gastrointestinal Oncology
- Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
- (2015) Younak Choi et al. PLoS One
- Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA)
- (2014) D. Blum et al. ANNALS OF ONCOLOGY
- Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma
- (2014) Alessandro Paniccia et al. MEDICINE
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
- (2013) Brian A. Boone et al. JOURNAL OF SURGICAL ONCOLOGY
- The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
- (2013) Thierry Conroy et al. Current Oncology Reports
- Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
- (2012) Katie M. Di Sebastiano et al. BRITISH JOURNAL OF NUTRITION
- Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
- (2012) Peter Peng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Obesity and Weight Loss at Presentation of Lung Cancer are Associated with Opposite Effects on Survival
- (2011) Relin Yang et al. JOURNAL OF SURGICAL RESEARCH
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
- (2011) Elias Assaf et al. ONCOLOGY
- STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
- (2011) Andrea Bonetto et al. PLoS One
- Adipose tissue pathways involved in weight loss of cancer cachexia
- (2010) I Dahlman et al. BRITISH JOURNAL OF CANCER
- Cachexia as a major underestimated and unmet medical need: facts and numbers
- (2010) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Cytokine gene polymorphisms and susceptibility to cachexia
- (2010) Benjamin HL Tan et al. Current Opinion in Supportive and Palliative Care
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Cachexia: prevalence and impact in medicine
- (2008) Benjamin HL Tan et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now